Bank of America’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-24,500
Closed -$408K 8656
2013
Q3
$408K Buy
+24,500
New +$362K ﹤0.01% 4816

Other funds holding OSIR

Bank of America's OSIR Position: Q2 2019 in Review

Bank of America sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 83,046 shares — an estimated $1.58M sold.

Bank of America first reported a position in OSIR in Q2 2013 and held it in 18 quarters. The position peaked at $1.58M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Bank of America reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Bank of America sold 83,046 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.58M.
  • Bank of America first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
  • Bank of America's Osiris Therapeutics, Inc. Common Stock position peaked at $1.58M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Bank of America's 13F filing for Q2 2019, filed 14 Aug 2019.